BGM
Qilian International Holding Group LimitedNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$108.77M
P/E Ratio
—
EPS
$-0.17
Beta
1.46
52W High
$11.80
52W Low
$0.25
50-Day MA
$0.32
200-Day MA
$2.37
Dividend Yield
—
Profit Margin
-52.60%
Forward P/E
—
PEG Ratio
—
About Qilian International Holding Group Limited
Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company is headquartered in Jiuquan, the People's Republic of China.
Fundamentals
| Revenue (TTM) | $37.92M |
| Gross Profit (TTM) | $6.31M |
| EBITDA | $-11.12M |
| Operating Margin | -43.80% |
| Return on Equity | -9.27% |
| Return on Assets | -3.23% |
| Revenue/Share (TTM) | $0.34 |
| Book Value | $1.95 |
| Price-to-Book | 0.01 |
| Price-to-Sales (TTM) | 2.87 |
| EV/Revenue | 2.842 |
| EV/EBITDA | -2.48 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 88.30% |
| Shares Outstanding | $380.62M |
| Float | $133.30M |
| % Insiders | 38.05% |
| % Institutions | 0.10% |
Historical Volatility
HV 10-Day
50.69%
HV 20-Day
61.16%
HV 30-Day
74.54%
HV 60-Day
125.37%
HV Rank
—
Volatility is currently contracting
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on BGM and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 8/18/2026